Who We Are

CanRIO is a network of Canadian rheumatologists and researchers with expertise in the management of the rheumatic complications of cancer immunotherapy. These include the development of new rheumatic conditions which develop during or after treatment with immunotherapy, termed rheumatic immune related adverse events (Rh ir-AE) and on the management of patients with rheumatic disease who are being treated or being considered for treatment with immunotherapy.

Site content continues to be developed and will be updated on a continuous basis as emerging evidence becomes available.  Please check back frequently!

Read More

Mission Statement

To improve the care of cancer patients across Canada receiving immunotherapy, who develop rheumatic complications or have pre-existing autoimmune conditions, through collaboration, education and research.

Would you like to support CanRIO? Your donation will help fund critical research to help us understand how best to diagnose and treat side effects of immunotherapy in cancer patients. Click on the link below to make a donation through Arthritis Research Canada and enter “CanRIO” in the message area to ensure your support is dedicated to CanRIO research projects.

News from CanRIO

Upcoming Case Rounds

Case Rounds

CanRIO is thrilled to host Dr. Carrie Ye (University of Alberta) for our upcoming case rounds, a collaboration with McMaster… Read More

Studies from CanRIO

Early Adalimumab Induction for Treatment of…

Work in progress! Dr. Shahin Jamal and Dr. Tom Appleton are leading a study on Early Adalimumab Induction for Treatment… Read More

CanRIO Recommendations for the Assessment and…

Coming 2024/2025! With support from the Canadian Rheumatology Association (CRA) Guidelines Committee, CanRIO has assembled a working group of rheumatologists,… Read More

General Updates

CanRIO Researcher Awarded an Arthritis Society of…

Congratulations to Dr. Marie Hudson who has been awarded a Arthritis Society of Canada grant to study the mechanisms underlying… Read More

CanRIO Researchers Awarded a 2023 CIORA Grant!

Congratulations to Dr. Shahin Jamal and Dr. Tom Appleton on receiving a Canadian Initiative for Outcomes in Rheumatology cAre (CIORA)… Read More